- STAT+: What’s in the last-minute flurry of health care bills?Congress is scrambling to advance a slew of health care bills before an August recess. Price transparency and prior authorization top the list.STAT · 1d ago↗ source
- FDA panel confronting peptide controversyToday's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."STAT · 1d ago↗ source
- A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribingHas a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare disease? Find out on this week's episode of…STAT · 1d ago